Control Bionics Ltd
ASX:CBL
Control Bionics Ltd
ASX:CBL
Price:
0.043 AUD
Market Closed
Updated:
May 4, 2024
Section:
Relative Value
The Relative Value of one
CBL
stock under the Base Case scenario is
0.128
AUD.
Compared to the current market price of 0.043 AUD,
Control Bionics Ltd
is
Undervalued by 66%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
CBL
Relative Value
Base Case
0.128
AUD
Undervaluation 66%
Valuation Multiples
Multiples Across Competitors
CBL Competitors Multiples
Control Bionics Ltd Competitors
Control Bionics Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| AU |
|
Control Bionics Ltd
ASX:CBL
|
5.1m AUD | 0.8 | -1.1 | -0.8 | -0.8 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
183.6B USD | 4.6 | 32.6 | 19.2 | 28.6 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
135.3B USD | 18.5 | 68.1 | 55.8 | 70 | |
| US |
|
Stryker Corp
NYSE:SYK
|
125.1B USD | 6 | 37.2 | 24.2 | 29.7 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
108.6B USD | 3.4 | 25.9 | 13.8 | 19.5 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
106.8B USD | 7.3 | 60.5 | 30.8 | 45.5 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
67.8B USD | 3.5 | 55.6 | 18.6 | 39.4 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
57.9B EUR | 2.7 | 38.1 | 18.3 | 30.9 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
51.3B USD | 8.4 | 36.3 | 26.4 | 28.5 | |
| US |
|
Dexcom Inc
NASDAQ:DXCM
|
50.8B USD | 13.4 | 79.5 | 59.5 | 77.4 | |
| CN |
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
368.4B CNY | 10.7 | 32.5 | 28.3 | 28.3 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
You don't have any saved screeners yet
